45 results
8-K
EX-99.1
AUTL
Autolus Therapeutics plc
1 Apr 24
Departure of Directors or Certain Officers
7:06am
governance experience to the Board and Ravi Rao, M.D., adds clinical development and medical affairs experience in autoimmune and inflammatory disease
8-K
AUTL
Autolus Therapeutics plc
1 Apr 24
Departure of Directors or Certain Officers
7:06am
On March 26, 2024, the Board, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Michael W. (“Mike … .
In addition, on March 26, 2024, the Board, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Ravi M. Rao
10-K
2023 FY
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
, regulators, self-regulatory organizations and other stakeholders have expressed an interest in Environmental, Social and Corporate Governance (“ESG”) matters … disclosure and financial controls and corporate governance practices. Our senior management and other personnel will need to devote a substantial
10-K
2023 FY
EX-10.12
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
................................................................................................................................ 1 2. SCOPE AND GOVERNANCE … , or [***]. For the purpose of this definition, [***]. 2. SCOPE AND GOVERNANCE 2.1 Collaboration Overview. Under and pursuant to the terms
8-K
EX-1.1
AUTL
Autolus Therapeutics plc
8 Feb 24
Autolus Announces Pricing of Underwritten Offering
4:17pm
to loans and Sections 302 and 906 related to certifications and (ii) the corporate governance requirements under regulations of The Nasdaq Stock Market LLC
8-K
EX-10.3
omy76gtmh lpwapd0z
8 Feb 24
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
6:06am
8-K
rr84b
10 Jan 24
Departure of Directors or Certain Officers
3:12pm
8-K
EX-99.1
o2mik1bd91nzua0
22 Dec 23
Departure of Directors or Certain Officers
8:24am
8-K
bnm1kosxewa 7v
22 Dec 23
Departure of Directors or Certain Officers
8:24am
6-K
EX-99.1
m1aybhrx7jrl2ff2
20 Jun 23
Current report (foreign)
4:59pm
6-K
co7eq246x3cx3d
20 Jun 23
Current report (foreign)
4:59pm
6-K
EX-1.1
dckzg8pdq6et
9 Dec 22
Autolus Announces Pricing of Public Offering
5:43pm
424B5
ynli88yd2t866qqmjjt2
9 Dec 22
Prospectus supplement for primary offering
5:40pm
424B5
97vtbhom s7vd1z
8 Dec 22
Prospectus supplement for primary offering
4:10pm
6-K
EX-1
4lrub0jze y0gobsu
1 Jul 22
Current report (foreign)
5:15pm
424B3
9eqo87
18 May 22
Prospectus supplement
4:09pm
F-3
7malxhssi130w iym0
3 May 22
Shelf registration (foreign)
7:25pm
424B3
zf709ma
3 May 22
Prospectus supplement
4:55pm
F-3
y99w57qx8c pjg9y9q
14 Apr 22
Shelf registration (foreign)
9:30pm